Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gail Frances Mcintyre currently holds 65,490 shares of Furiex Pharmaceuticals, Inc. (FURX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gail Frances Mcintyre has been a net seller of FURX stock. They have purchased $161.3K and sold $9.2M worth of shares.
Gail Frances Mcintyre's most recent insider trade was on Oct 24, 2022, when they sold 54,353 shares at $0.92 per share.
Gail Frances Mcintyre serves as Executive at Furiex Pharmaceuticals, Inc. (FURX). They have executed 21 insider transactions totaling $9.4M over their tenure at the company.
Gail Frances Mcintyre holds the position of Executive at Furiex Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Gail Frances Mcintyre has shown a selling trading pattern, with $161.3K in total purchases and $9.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gail Frances Mcintyre was on Jun 16, 2014, when they sold $3.5M worth of FURX shares. This transaction involved 32,928 shares at $105.00 per share.
Gail Frances Mcintyre currently owns 65,490 shares of Furiex Pharmaceuticals, Inc. (FURX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gail Frances Mcintyre's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gail Frances Mcintyre has 21 Form 4 filings on record as an insider at Furiex Pharmaceuticals, Inc..
Set alerts for Gail Frances Mcintyre and 40,000+ other insiders.